Europe after North America is the second largest market leading the cancer screening market. The market is forecasted to grow at a compound annual growth rate of (CAGR) of 8.1% resulting in an annual revenue of USD 22.43 Bn during the forecast period (2018-2023). Increase in the aging population along with the rise in the number of cancer incidences is a key driving factor for the market. Western Europe is moving fast towards the adoption of performance-based remuneration systems.
... Read more

Certain tests help find precise types of cancer before signs or symptoms appear, called cancer screening. It main goal is to reduce the number of people who develop the disease and reduce the number of people who die from disease & prevent deaths from cancer altogether. It involves urine tests, blood tests and medical imaging tests.

Some of the risk associated with cancer screening are increased testing, false positives test results, over ... Read more